Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-284298
Filing Date
2024-12-23
Accepted
2024-12-23 17:14:28
Documents
3
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 6-K d891803d6k.htm 6-K 9232
2 EX-99.1 d891803dex991.htm EX-99.1 9460
3 GRAPHIC g891803g1224020503990.jpg GRAPHIC 3287
  Complete submission text file 0001193125-24-284298.txt   24378
Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41842 | Film No.: 241574838
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)